ATE462780T1 - Stabile, herg darstellende zellkulturen - Google Patents

Stabile, herg darstellende zellkulturen

Info

Publication number
ATE462780T1
ATE462780T1 AT06125765T AT06125765T ATE462780T1 AT E462780 T1 ATE462780 T1 AT E462780T1 AT 06125765 T AT06125765 T AT 06125765T AT 06125765 T AT06125765 T AT 06125765T AT E462780 T1 ATE462780 T1 AT E462780T1
Authority
AT
Austria
Prior art keywords
stable
herg
cell cultures
representing cell
representing
Prior art date
Application number
AT06125765T
Other languages
English (en)
Inventor
Paul Shartzer Dietrich
Ulrich Andreas Gubler
Heather Guthrie
Bruce Koch
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE462780T1 publication Critical patent/ATE462780T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Golf Clubs (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT06125765T 2005-12-21 2006-12-11 Stabile, herg darstellende zellkulturen ATE462780T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75301505P 2005-12-21 2005-12-21
US84196506P 2006-09-01 2006-09-01

Publications (1)

Publication Number Publication Date
ATE462780T1 true ATE462780T1 (de) 2010-04-15

Family

ID=37891741

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06125765T ATE462780T1 (de) 2005-12-21 2006-12-11 Stabile, herg darstellende zellkulturen

Country Status (9)

Country Link
US (2) US7776590B2 (de)
EP (1) EP1801200B1 (de)
JP (1) JP4464954B2 (de)
CN (1) CN100516205C (de)
AT (1) ATE462780T1 (de)
CA (1) CA2571339C (de)
DE (1) DE602006013258D1 (de)
ES (1) ES2340604T3 (de)
SG (1) SG133563A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101498723A (zh) * 2009-02-27 2009-08-05 深圳先进技术研究院 离子通道药物筛选装置及方法
CN116355835B (zh) * 2023-03-30 2026-05-26 武汉合研生物医药科技有限公司 一种提高膜片钳试验时hERG-HEK293细胞稳定性的铺板方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2459265A1 (en) 2001-09-04 2003-03-13 Pfizer Inc. Affinity-assay for the human erg potassium channel
SE0104251D0 (sv) * 2001-12-14 2001-12-14 Astrazeneca Ab Novel compounds
US7510874B2 (en) * 2003-10-28 2009-03-31 Wisconsin Alumni Research Foundation Stable cell lines expressing HERG1a and HERG1b
EP1690933B1 (de) * 2003-11-17 2013-04-24 Eisai R&D Management Co., Ltd. Herg-kanal exprimierende zelle

Also Published As

Publication number Publication date
CA2571339A1 (en) 2007-06-21
ES2340604T3 (es) 2010-06-07
EP1801200A1 (de) 2007-06-27
US8349572B2 (en) 2013-01-08
DE602006013258D1 (de) 2010-05-12
JP2007167068A (ja) 2007-07-05
US20070141554A1 (en) 2007-06-21
US20100261191A1 (en) 2010-10-14
CA2571339C (en) 2010-05-04
CN1986783A (zh) 2007-06-27
US7776590B2 (en) 2010-08-17
EP1801200B1 (de) 2010-03-31
JP4464954B2 (ja) 2010-05-19
SG133563A1 (en) 2007-07-30
CN100516205C (zh) 2009-07-22

Similar Documents

Publication Publication Date Title
CL2009001263S1 (es) Maquina de afeitar.
CL2009001380S1 (es) Mango de maquina de afeitar.
CL2007002182S1 (es) Terminal.
MX2009013706A (es) Celulas multipotentes/pluripotentes y metodos relacionados.
ATE538616T1 (de) Steuerung der wachzeit einer mobilvorrichtung
EP1951933A4 (de) Kontinuierliche elektrochemische gleichstrom-reduktion von kohlendioxid
NZ597438A (en) Systems and methods for selecting a network access system
BRPI0916851A2 (pt) separação de dióxido de carbono e hidrogênio.
CL2009000063S1 (es) Mango para maquina de afeitar.
MX346001B (es) Polipeptidos de eritropoyetina animal modificados y sus usos.
IN2014CN03629A (de)
CR9930A (es) Compuestos
MX2010002028A (es) Metodos y composiciones para modular celulas t.
BR112013033139A2 (pt) métodos e equipamentos para aprimorar os mecanismos de atualização de parâmetros de nfc
WO2007133488A3 (en) Framework for agile mobile applications
GEAP201813723A (en) Anti-gcc antibody molecules and related compositions and methods
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
CL2009001363S1 (es) Pieza para maquina de afeitar.
EA201171332A1 (ru) Композиция для стерилизации поверхностей
UY34360A (es) ?compuestos de tipo bisamida con actividad insecticida, procesos e intermediarios?
DE602006013258D1 (de) Stabile, hERG darstellende Zellkulturen
ATE556446T1 (de) Batterieanoden
WO2006006080A3 (en) Sodium channel agonist
ATE492133T1 (de) Dynamische bereitstellung einer dienstqualität für einen mobilen knoten
WO2009004664A3 (en) Immortalized cell line of murine mesenchymal stem cells, method for preparation and uses thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties